My Learning Cart
?
Categories
Account

In 2022, which company announced a partnership to develop mRNA vaccines for infe

₹0.0
Login to Download
  • 📥 Instant PDF Download
  • ♾ Lifetime Access
  • 🛡 Secure & Original Content

What’s inside this PDF?

Question: In 2022, which company announced a partnership to develop mRNA vaccines for infectious diseases beyond COVID-19?

Options:

  1. Pfizer
  2. Novavax
  3. Sanofi
  4. Johnson & Johnson

Correct Answer: Pfizer

Solution: 

Pfizer announced a partnership in 2022 to develop mRNA vaccines targeting various infectious diseases beyond COVID-19.

In 2022, which company announced a partnership to develop mRNA vaccines for infe

Practice Questions

Q1
In 2022, which company announced a partnership to develop mRNA vaccines for infectious diseases beyond COVID-19?
  1. Pfizer
  2. Novavax
  3. Sanofi
  4. Johnson & Johnson

Questions & Step-by-Step Solutions

In 2022, which company announced a partnership to develop mRNA vaccines for infectious diseases beyond COVID-19?
  • Step 1: Identify the year mentioned in the question, which is 2022.
  • Step 2: Look for companies that announced partnerships in 2022.
  • Step 3: Focus on partnerships related to mRNA vaccines.
  • Step 4: Confirm that the partnership is for developing vaccines for infectious diseases beyond COVID-19.
  • Step 5: Conclude that Pfizer is the company that made this announcement.
  • mRNA Vaccine Development – The process of creating vaccines using messenger RNA technology to target infectious diseases.
  • Partnerships in Biotechnology – Collaborations between companies to leverage expertise and resources in vaccine development.
  • Infectious Diseases – Diseases caused by pathogens that can spread from person to person, necessitating vaccine development.
Soulshift Feedback ×

On a scale of 0–10, how likely are you to recommend The Soulshift Academy?

Not likely Very likely
Home Practice Performance eBooks